Laurus Labs Ltd IPO Message Board (Page 58)

Laurus Labs IPO

Day 2 at 12:30PM

QIB*: 0.85X (*Excluding Anchor)
NII: 0.17X
RII: 0.18X
Emp: 0.19X

Total : 0.37X

Applications: 37,650 Approx

Apply or Avoid ?

Great eagleye, as dilip sir told your doing good job.

eagleye should we apply laurus labs

Laurus Labs IPO

Day 2 at 12:00 Noon

QIB*: 0.71X (*Excluding Anchor)
NII: 0.17X
RII: 0.17X
Emp: 0.19X

Total : 0.32X

Applications: 34,850 Approx

Respected eagle eye , u r doing good job. I have been in the primary market since 1980. as per my assessment it is an apply issue. already submitted 5 application with 1 lot

when I apply I see in terms and conditions that "I/we hereby agree that I/we shall not make multiple application(s) for the Issue. "
is it legal to apply 5 applications?

Thanks for providing the figures Eagleye.

Can you please provide your view to apply with long term and short term view?

Laurus Labs IPO

Day 2 at 11:30AM

QIB*: 0.71X (*Excluding Anchor)
NII: 0.17X
RII: 0.16X
Emp: 0.19X

Total : 0.32X

Applications: 32,500 Approx

what is the optimum lot size to apply? 1 lot or more than 3 or 4?

is it good for long term?

Eagleye,thanks for ur information. Any idea how many times may subscribe?

On which date funds will get blocked.

For online.. as soon as you place your bid

Laurus Labs IPO

GMP 16 - 18
Kostak 500 - 600

I am applying ... with a target of Rs.470+ after 4 weeks of listing

I am applying for 13 lots in each application ... because I believe that the RII quota may not be fully subscribed

Cool...

Laurus Labs IPO

Day 2 at 10:45AM

QIB*: 0.71X (*Excluding Anchor)
NII: 0.17X
RII: 0.14X
Emp: 0.19X

Total : 0.30X

Applications: 27,800 Approx

Any subscription details please.

Dear Pawan,
These will be 10 rs more or less the price band.overlll this is a good IPO I feel.can you tell which company grown like laurus.I can say no company. This share will touch 2000 by 2019.this is internal expectations.

Thanks,

Reposting with Formatted "Peer comparison". Apologies for spamming with multiple messages.

When compared to its peers, the return ratios and earnings multiple of Laurus is not appealing.

Peer Comparison
       RONW      P/E (FY16 EPS)
Aurobindo 32.2       29
Divis 28.5      22
Laurus 15.6      34
Source: RHP, Equitymaster Research

Price to Earnings Multiple for the Given Price Band
FY16      FY17 (Annualized)
Price      Pre Issue      Post Issue      Pre Issue      Post Issue
426       31.7       34.0       28.0      30.0
428       31.9       34.1       28.1      30.1
In the near term, Aspen contract may likely provide good upside to the company''s business. However from the overall business perspective, company generates major portion of the business from APIs which have lower margin as compared to formulations. Since the issue is priced at the higher side and taking into account the risk factors, we recommend that one could consider AVOIDING the IPO.

Although the company has been primarily grown in the API business, CNBC TV had stated that their formulations business is ready for manufacturing and was recently audited. Given the formulation business has good margins and is relatively less volatile, the future prospects even within the short term look very positive.

Any one has any update on their other future plans for growth? Pls update me.

Final note of Equitymaster on Laurus Labs:

When compared to its peers, the return ratios and earnings multiple of Laurus is not appealing.

Peer Comparison
      RONW      P/E (FY16 EPS)
Aurobindo
32.2      29
Divis
28.5      22
Laurus
15.6      34
Source: RHP, Equitymaster Research

Price to Earnings Multiple for the Given Price Band
FY16      FY17 (Annualized)
Price      Pre Issue      Post Issue      Pre Issue      Post Issue
426      31.7      34.0      28.0      30.0
428      31.9      34.1      28.1      30.1
In the near term, Aspen contract may likely provide good upside to the company''s business. However from the overall business perspective, company generates major portion of the business from APIs which have lower margin as compared to formulations. Since the issue is priced at the higher side and taking into account the risk factors, we recommend that one could consider AVOIDING the IPO.

when Market is good, taking risk makes sense for over priced IPOs. Welcome comments from experts in this volatile market juncture.

Varun beverages look in trouble....may slip to 385.

gamble Any update on LAURUS???

Already bullish.see previous post.

inteha ho gayi intezaar ki
Kaha ho Eagleeye

How much PE. 35 OR 22 PLEASE TELL which one?

what is PE.tell me in detail.